Vireo Growth (VREOF) Change in Intangibles (2022)
Vireo Growth (VREOF) reported Change in Intangibles of $236635.0 for Q1 2022.
Vireo Growth (VREOF) Change in Intangibles (2022) Analysis & Trends
Vireo Growth (VREOF) has 1 years of Change in Intangibles data on file, last reported at $236635.0 in Q1 2022.
- For the quarter ending Q1 2022, Change in Intangibles changed N/A year-over-year to $236635.0; the trailing twelve-month figure through Dec 2022 stood at $236635.0 (changed N/A YoY), and the FY2022 full-year result was $236635.0, changed N/A from the prior year.
- Change in Intangibles steadied at $236635.0 in Q1 2022.
- In the past five years, Change in Intangibles ranged from a high of $236635.0 in Q1 2022 to a low of $236635.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn | -107.94 Mn |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 236,635.00 |
| Mar 31, 2022 | 236,635.00 |